Disinhibition, an emerging pharmacology of learning and memory

View/ Open
Published Version
https://doi.org/10.12688/f1000research.9947.1Metadata
Show full item recordCitation
Möhler, Hanns, and Uwe Rudolph. 2017. “Disinhibition, an emerging pharmacology of learning and memory.” F1000Research 6 (1): F1000 Faculty Rev-101. doi:10.12688/f1000research.9947.1. http://dx.doi.org/10.12688/f1000research.9947.1.Abstract
Learning and memory are dependent on interactive excitatory and inhibitory mechanisms. In this review, we discuss a mechanism called disinhibition, which is the release of an inhibitory constraint that effectively results in an increased activity in the target neurons (for example, principal or projection neurons). We focus on discussing the role of disinhibition in learning and memory at a basic level and in disease models with cognitive deficits and highlight a strategy to reverse cognitive deficits caused by excess inhibition, through disinhibition of α5-containing GABA A receptors mediating tonic inhibition in the hippocampus, based on subtype-selective negative allosteric modulators as a novel class of drugs.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302145/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731798
Collections
- HMS Scholarly Articles [17714]
Contact administrator regarding this item (to report mistakes or request changes)